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Fat deposition of parotid glands
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Parotid gland parenchyma histology may be altered by local or systemic, pathological or non-
pathological conditions.
Objective: This paper aims to highlight the fatty degeneration of the parotid gland, a not well-known 
non-pathological condition.
Method: In a retrospective study, we collected a series of 6 patients which presented a swelling of 
the parotid, but even after extensive research, a diagnosis was not reached.
Results: Through the retrospective analysis of records we found fatty degeneration of the parotid 
in an MRI scan of all patients.
Conclusion: This condition, despite being physiological and expected with aging, may be related 
to clinical and radiological swelling of these glands.
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INTRODUCTION
Parotid gland parenchyma is subject to chan-
ges in its histological characteristics because of local 
or systemic conditions. Hypertriglyceridemia may be 
associated with fat infiltration in the parotid without 
inflammatory activity1. The drop in ovarian hormones 
after ovariectomy in rats showed fat degeneration in 
the parotid glands2. In Sjögren’s syndrome, there is 
parenchyma heterogeneity because of adipose de-
generation and lymphocytic infiltration3. In patients 
with the Human Immunodeficiency Virus (HIV), there 
may be parotid gland enlargement and, histologically, 
besides the fat infiltration, one may see lymphocytic 
aggregates, lymphoepithelial cysts or lymphadenopa-
thy4. Moreover, in alcoholics and diabetics, there is a 
reduction in the rate of fat tissue in the stroma5. On 
the other hand, studies with rats have shown an in-
crease in lipids and degeneration of secretory granules 
associated with an age-related decline in the secretory 
activities of the parotid glands6, without it representing 
a disease process.
In the stomatology ward of our institution, we 
had patients in whom we saw an increase in the vo-
lume of the parotid glands, eventually associated with 
complaints resembling those of a Sjögren’s syndrome, 
but after broad diagnostic investigation, such condition 
was ruled out, based on current diagnostic criteria 
(European-American Consensus, 2002)7. By the same 
token, any other local or systemic conditions, such 
as sarcoidosis8 and lymphoma9, which would explain 
that situation, have just been discarded by means 
of pertaining propaedeutic. Nonetheless, during the 
diagnostic investigation process through an MRI, we 
noticed that a common point to them is the finding of 
liposubstitution of the parotid glands.
Therefore, this study aimed at informing about 
this pathology, which makes patients with this little-
-known pathology seek physicians.
METHOD
This is a historical cross-sectional cohort study, 
carried out with the charts of 6 patients seen in the 
stomatology ward of our institution, between February 
of 2009 and January of 2012.
The inclusion criterion was patients who had 
clinical signs of volumetric increase of the parotid 
glands, without any local or systemic conditions that 
would justify them, after the pertaining diagnostic 
investigation, by means of an image exam, laboratorial 
and/or anatomic-pathological tests (Figure 1). In the-
se cases, our investigation encompasses a complete 
blood count, antiSSB, anti-nucleus factor, rheumatoid 
factor, HIV, anti-HCV, Schirmer test, minor salivary 
gland biopsy, neck MRI, scintigraphy and, in selected 
cases: sialography.
Figure 1. Patient with bilateral parotid enlargement and liposubstitution 
seen upon MRI.
As for inclusion criterion, we defined the cases 
which were truly unilateral through the MRI.
Since it is a retrospective study based on 
information from patients’ charts, without patient 
identification, there was no need for informed 
consent forms.
The project was approved by the Clinical Board 
and by the Ethics in Research Committee of the insti-
tution, under protocol # 49.444/12.
RESULTS
Within the time frame considered (February of 
2009 through January of 2012), we admitted 483 new 
patients in our ward, of whom 64 (13.25%) had enlar-
ged parotids as their main complaint, and six (1.24%) 
fit the inclusion criteria.
Upon MRI, the fat deposits on the parotids was 
seen by a T1 hypersignal; in fat suppression sequences, 
the suppressed sites are identified by hyposignal (T1 
with contrast and T2)10 (Figures 2 and 3).
The results obtained were plotted on the table 
below (Table 1).
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Figure 2. Axial section in T1 without contrast, showing hypersignal 
from the parotids.
Figure 3. Axial section in T1 with contrast and fat suppression, showing 
hyposignal in the areas in which fat was suppressed.
Table 1. Information from the patients who fit the inclusion criteria.
1st visit Gender Age of onset Complaint Alcoholism Smoking Physical exam MRI
02/21/09 M 58
Parotid bulging for 
8 months, recurrent, 
bilateral and painful, 
with xerostomy
No No
Mild bilateral 
enlargement of the 
parotids, larger on the 
left, fibroelastic
Bilateral parotid volume 
enlargement, with fat 
substitution signs, 
without nodules
10/06/09 M 68
Bilateral parotid bulging 
for 1 year, without 
salivary complaints
No No
Bilateral salivary gland 
bulging, especially the 
parotids
Parotid parenchyma 
replacement for fat, with 
some small lymph nodes
10/06/09 F 46 Bilateral parotid bulging for 1 year No Yes
Diffuse parotid 
enlargement, fibroelastic
Liposubstitution and pa-
rotid volume enlargement
05/10/11 F 33
Right parotid bul-
ging for 3 years, mild 
xerostomy
No No Right-side parotid volu-me enlargement
Volume enlargement and 
parotid liposubstitution
11/29/11 M 55 Parotid bulging for 4 months, with xerostomy Yes No
Mild bilateral and fibro-
elastic parotid enlar-
gement
Diffuse parotid 
enlargement, with 
liposubstitution
01/31/12 F 46
Recurrent right side, 
painful bulging for 2 
years
No No
Right-side parotid 
enlargement, mildly 
painful upon palpation
Parotid liposubstitution 
and small intraparotid 
lymph nodes
The data collected point to three male patients 
and three females; therefore, there was no gender dis-
tinction. Age of onset varied between 33 and 68 years, 
with a mean age of 51 (± 12.06) years. The trait was 
recurrent in two patients (33.33%), being constant in 
the others. In all the patients, the parotid consistency 
was firm/fibroelastic, without irregularities or inflam-
matory signs, although mildly painful in one patient. 
We stress that xerostomy was complained by three 
patients (50%), confirmed upon clinical exam; notwi-
thstanding, these patients were submitted to parotid 
gland scintigraphy, without any change in the tests. 
As far as habits are concerned, one patient (16.67%) 
reported being an ex-smoker and one patient (16.67%) 
reported mild alcohol consumption. In all the patients 
we found signs of liposubstitution of the parotid glands 
upon the MRI in both parotids, although in two cases 
they were unilateral.
We stress that the 64 cases of parotid enlarge-
ment in our ward had the following diagnosis: Sjögren’s 
syndrome (15), repeating parotiditis of childhood (13), 
sialadenitis (7), infectious (7), tumoral (5), intraparotid 
cyst (4), HIV (2), lymphoma (2), alcoholic (1), sarcoi-
dosis (1), liposubstitution (7). Of these four cases in 
which we found parotid liposubstitution, one case was 
taken off the study since the MRI showed unilateral 
changes.
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DISCUSSION
Parotid liposubstitution is a frequent radiologic 
finding; however, the literature does not have papers 
correlating idiopathic parotid bulging with its presence. 
It is known that this is a natural physiological pro-
cess, like aging6 (we stress that the mean age of our 
sample was 51 years); however, subject to variations 
in accordance with the presence of subjacent clinical 
conditions1-5. In fact, the parotid liposubstitution with 
the Sjögren’s syndrome is known, after having been 
demonstrated by Niemela et al.11, in a study involving 
26 patients with the primary form of the disease, and 
changes (nodules or adipose degeneration in the pa-
renchyma) were seen in 81% of the cases.
On the other hand, our series was made up 
of individuals without local or systemic diseases, 
exhaustively investigated, they presented parotid 
liposubstitution as a common denominator, which 
leads us to think that, in some cases, this is not a 
mere histological transformation as per expected with 
the gland aging, having a clinical and radiological 
manifestation of parotid enlargement. Parotid bulging 
was recurrent in two patients, which is not expected 
for a supposedly slow and gradual process. And fi-
nally, there are issues which still cannot be cleared 
up, especially since this is a theme with very little 
presence in the medical literature.
CONCLUSION
Parotid liposubstitution, although a physiologi-
cal process - expected with aging, may be associated 
with a bilateral enlargement of the glands in indivi-
duals who do not have systemic or local causes for 
such condition. However, some issues related to this 
association, remain open, and may be investigated 
in new studies.
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